Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study to Assess the Safety and Feasibility of Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Intravenous Bevacizumab-800CW.

NCT05497726 is registered in ClinicalTrials.gov with Meander Medical Center as lead sponsor.

NCT NCT05497726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05497726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study to Assess the Safety and Feasibility of Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Intravenous Bevacizumab-800CW.
Lead sponsor
Meander Medical Center
Phase
Not applicable
Overall status
Completed
Start date
January 27, 2023
Completion date
October 10, 2023
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon neoplasm, colorectal neoplasms, fluorescence, sentinel lymph node